NxStage Medical (NXTM) Tops Q4 EPS by 2c

NxStage Medical (NASDAQ: NXTM) reported Q4 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $79.9 million versus the consensus estimate of $75.75 million.

For earnings history and earnings-related data on NxStage Medical (NXTM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat